Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Endorses Increased Dispensing Fees For Inhalation Drugs

Executive Summary

The Centers for Medicare & Medicaid Services believes that $55 to $64 per month is an appropriate range for inhalation therapy dispensing fees in 2005

You may also be interested in...



Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says

CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006

Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says

CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006

Inhalation Drugs Will Have $57 “Transitional” Dispensing Fee In 2005

The Centers for Medicare & Medicaid Services is increasing the dispensing fee for inhalation drugs delivered via nebulizers by over 1,000% as a means of managing the transition of the inhalation therapy market during 2005

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel